In this free webinar, attendees will gain insights into the challenges of cannabinoid analysis owing to the proliferation of THC analogues and the use of advanced methodologies for accurate analysis. The featured speaker will discuss the analytical challenges posed by emerging THC analogues due to their structural similarities, necessitating the use of advanced methodologies for accurate analysis. They will also learn about how commercially available products containing THC analogues are often mislabelled and may contain additional analogues, highlighting the need for stringent regulatory oversight and consumer awareness.
TORONTO, May 7, 2024 /PRNewswire-PRWeb/ -- The passage of the 2018 Farm Bill, or Agricultural Improvement Act of 2018, allowed for the removal of hemp from the Drug Enforcement Administration's (DEA) list of controlled substances. Since the passage of the Farm Bill, the hemp market has become saturated. The 2023 National Hemp Report from the National Agricultural Statistics Service (NASS) reported over 30 million pounds of hemp produced in 2022, down from 39 million pounds produced in 2021.
Unrestrained hemp production has led to an excess of hemp's most abundant phytocannabinoid, cannabidiol (CBD). The CBD market has largely targeted health-conscious individuals in search of alternatives to pharmaceuticals. CBD is promoted in the health and fitness industry to enhance muscle recovery, reduce inflammation and pain and decrease cortisol levels.
While the CBD market was projected to continue to grow, the market has become saturated with CBD products. As a result of this saturated market, CBD has been used to synthesize a variety of natural and unnatural tetrahydrocannabinol (THC) isomers and analogues. These products advertise the presence of THC isomers, and other analogues such as hexahydrocannabinol (HHC), tetrahydrocannabiphorol (THCP) and THC-acetate (THC-O).
These cannabinoids are commercially available and are often sold as "hemp-derived" and "legal." Despite some of these compounds being found naturally in the plant material, the reported concentrations of marketed products exceeded the concentrations found naturally. With increasing number of cannabinoid derivatives being synthesized, there is a continuing need to develop methods for cannabinoid analysis.
In this webinar, the expert speaker will focus on the intricate dynamics of the CBD market and the direct correlation between the CBD market's saturation and proliferation of THC isomers and analogues. The speaker will also discuss the analytical challenges posed by emerging THC analogues due to their structural similarities, necessitating the use of advanced methodologies for accurate analysis.
Moreover, the speaker will discuss the prevalent mislabeling practices in commercially available THC analogue products, often leading to the presence of additional, unreported analogues, emphasizing the need for stringent regulatory oversight and consumer awareness.
Register for this webinar today to gain insights into the challenges of cannabinoid analysis owing to the proliferation of THC analogues and the use of advanced methodologies for accurate analysis.
Join the featured speaker Kimberly Karin, Chemist, Federal Aviation Administration, for the live webinar on Wednesday, May 22, 2024, at 1pm EDT (6pm BST/UK).
For more information, or to register for this event, visit Cannabinoid Analysis: Challenges Caused by the Proliferation of THC Isomers and Analogues.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article